Affinage

PCBD1

Pterin-4-alpha-carbinolamine dehydratase · UniProt P61457

Length
104 aa
Mass
12.0 kDa
Annotated
2026-06-10
32 papers in source corpus 15 papers cited in narrative 15 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 8/8 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

PCBD1 (DCoH/PCD) is a bifunctional homotetrameric protein that couples tetrahydrobiopterin metabolism to HNF1-dependent transcription (PMID:1465414). As an enzyme it is identical to 4a-carbinolamine dehydratase, regenerating tetrahydrobiopterin for the phenylalanine hydroxylation system through general acid catalysis by His61 and His79, which stereospecifically eliminate the 4a(R)- and 4a(S)-hydroxyl groups, while His62 binds substrate at active-site clefts lined by conserved histidines (PMID:1465414, PMID:9698371, PMID:8897596). The same protein acts as a dimerization cofactor (DCoH) by binding as a dimer to the helical dimerization domain of HNF1, forming a 2:2 heterotetramer through a mixed four-helix bundle; the homotetramer presents saddle-shaped grooves flanked by enzyme active sites that spatially link the two activities (PMID:7744010, PMID:7725101). This interaction stabilizes HNF1/DNA complexes, promotes binding to sub-optimal target sites, and abolishes HNF1-RNA interactions, and proceeds independently of dehydratase catalytic activity (PMID:8995521, PMID:9092652). Through this coactivator function PCBD1 stimulates HNF1B-driven transcription of FXYD2 in the renal distal convoluted tubule and forms a DCoH/HNF1alpha complex on the tyrosinase promoter in melanocytes, driving pigment cell differentiation (PMID:24204001, PMID:12565907, PMID:10704830). PCBD1 also has HNF1-independent roles, acting as a maternal nuclear factor in early embryogenesis and being required for establishment of early pancreatic fate (PMID:9496786, PMID:24848070). Loss of PCBD1 in mice causes hyperphenylalaninemia with only mild impairment of HNF1 function because the paralog DCoH2/PCBD2 — itself a tetrameric dehydratase that binds HNF1alpha — partially compensates (PMID:12011081, PMID:15182178). Disease-causing PCBD gene mutations (e.g. T78I, E86X, Q97X) cause primapterinuria/hyperphenylalaninemia primarily through proteolytic instability of the protein rather than direct catalytic disruption (PMID:9585615, PMID:24204001).

Mechanistic history

Synthesis pass · year-by-year structured walk · 13 steps
  1. 1992 High

    Established that a single polypeptide carries both pterin dehydratase activity and the dimerization-cofactor function regulating HNF1alpha, resolving whether these were separate proteins.

    Evidence Protein purification, dehydratase assay, phenylalanine hydroxylase stimulation, and cDNA cloning showing DCoH is identical to 4a-carbinolamine dehydratase

    PMID:1465414

    Open questions at the time
    • Structural basis for coupling the two activities not yet defined
    • HNF1 binding mode unresolved at residue level
  2. 1995 High

    Defined the architecture connecting catalysis and transcriptional coactivation by showing the homotetramer has saddle grooves flanked by active sites and binds HNF1 as a 2:2 heterotetramer.

    Evidence Independent X-ray crystal structures at 3 Å and 2.7 Å, the latter mapping the HNF1 dimerization-domain interaction

    PMID:7725101 PMID:7744010

    Open questions at the time
    • Ligand-bound active-site geometry not yet resolved
    • Functional consequence of HNF1 binding on DNA recognition not yet demonstrated
  3. 1996 High

    Pinpointed the pterin-binding pocket and the histidine constellation constraining the dehydration mechanism, advancing from architecture to catalytic detail.

    Evidence 2.3 Å crystal structure of DCoH bound to the product analogue 7,8-dihydrobiopterin

    PMID:8897596

    Open questions at the time
    • Catalytic roles of individual histidines not yet functionally tested
  4. 1997 High

    Demonstrated the functional output of complex formation — stabilization of HNF1/DNA binding, broadened site recognition, and loss of RNA interaction — and that catalysis is dispensable for HNF1 binding.

    Evidence In vitro binding and gel-shift assays with purified heterotetramers, enzymatic activity assays, plus yeast two-hybrid with enzymatic mutants and co-localization in co-transfected cells

    PMID:8995521 PMID:9092652

    Open questions at the time
    • Endogenous target genes not yet identified
    • Cellular regulation of nuclear versus cytoplasmic partitioning unaddressed
  5. 1998 High

    Resolved the catalytic mechanism at the residue level, assigning His61/His79 as stereospecific general acid catalysts and His62 as substrate-binding base.

    Evidence Site-directed mutagenesis with kinetic analysis on stereospecific substrate enantiomers and diethylpyrocarbonate modification

    PMID:9698371

    Open questions at the time
    • Does not address how catalysis relates to coactivator function
  6. 1998 Medium

    Explained how PCBD mutations cause disease, showing hyperphenylalaninemia/primapterinuria arises from proteolytic instability rather than direct active-site disruption.

    Evidence Genomic mutation analysis (T78I, E86X, Q97X) with recombinant expression and solubility fractionation

    PMID:9585615

    Open questions at the time
    • Single-lab solubility assay; in vivo turnover not measured
    • Effect on HNF1 transcriptional output not tested
  7. 1998 Medium

    Revealed HNF1-independent nuclear functions by detecting DCoH as a maternal factor entering nuclei during early development in tissues lacking HNF1.

    Evidence Immunofluorescence and Western blotting across rat developmental stages

    PMID:9496786

    Open questions at the time
    • Nuclear binding partners in HNF1-negative tissues unidentified
    • Functional role of maternal localization untested
  8. 2000 Medium

    Separated coactivator from enzymatic function in vivo, showing catalytically dead mutants still drive pigment cell differentiation.

    Evidence Xenopus overexpression with dehydratase-impaired mutants, tyrosinase activity and melanin quantification

    PMID:10704830

    Open questions at the time
    • Direct transcriptional target in pigmentation not yet identified
    • Single-lab overexpression system
  9. 2002 High

    Established physiological function and redundancy in vivo, showing knockout causes hyperphenylalaninemia but only mild HNF1 defects due to compensation.

    Evidence Targeted gene deletion in mice with metabolic and glucose-tolerance phenotyping

    PMID:12011081

    Open questions at the time
    • Degree of DCoH2 compensation per tissue not quantified
    • Glucose intolerance mechanism not dissected
  10. 2003 Medium

    Identified tyrosinase as a direct transcriptional target of the DCoH/HNF1alpha complex in melanocytes, grounding the pigmentation role in a promoter event.

    Evidence EMSA on the tyrosinase promoter and co-localization in human epidermal melanocytes

    PMID:12565907

    Open questions at the time
    • Single-lab study; in vivo promoter occupancy by ChIP not shown
  11. 2004 High

    Defined the compensating paralog DCoH2 mechanistically, showing it is a tetrameric dehydratase that binds HNF1alpha but, unlike hyperstable DCoH, exchanges into HNF1 complexes thermodynamically.

    Evidence 1.6 Å crystal structure of DCoH2, dehydratase and HNF1alpha binding assays, phylogenetic analysis

    PMID:15182178

    Open questions at the time
    • Tissue-specific division of labor between paralogs not resolved
  12. 2013 High

    Connected PCBD1 to renal HNF1B signaling and human disease, showing it coactivates FXYD2 transcription and that most disease mutations destabilize the protein and cause cytoplasmic mislocalization.

    Evidence Reciprocal co-IP, FXYD2 promoter-reporter assays, immunofluorescence localization and stability assays across multiple mutants in human kidney cells, plus mouse DCT expression

    PMID:24204001

    Open questions at the time
    • In vivo renal phenotype of mutations not modeled
    • Mechanism coupling HNF1B loss to PCBD1 cytoplasmic retention unresolved
  13. 2014 Medium

    Extended PCBD1 function to pancreatic development, showing it is required for establishing early pancreatic fate in the endoderm.

    Evidence Morpholino knockdown in Xenopus with insulin co-localization in mouse and Xenopus pancreas

    PMID:24848070

    Open questions at the time
    • Single-lab morpholino loss-of-function; HNF1 dependence of pancreatic role not tested
    • Downstream transcriptional targets in pancreas unknown

Open questions

Synthesis pass · forward-looking unresolved questions
  • How the spatial partitioning between cytoplasmic dehydratase and nuclear coactivator pools is regulated, and what targets mediate the HNF1-independent developmental roles, remain unresolved.
  • No identified regulator of nuclear/cytoplasmic shuttling
  • HNF1-independent nuclear partners and targets unknown
  • Genome-wide HNF1-PCBD1 target set undefined

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0016829 lyase activity 3 GO:0060090 molecular adaptor activity 3 GO:0140110 transcription regulator activity 3 GO:0016787 hydrolase activity 2
Localization
GO:0005634 nucleus 3 GO:0005829 cytosol 2
Pathway
R-HSA-1430728 Metabolism 3 R-HSA-74160 Gene expression (Transcription) 3 R-HSA-1266738 Developmental Biology 2
Partners
HNF1AHNF1B
Complex memberships
PCBD1 homotetramerPCBD1-HNF1 2:2 heterotetramer

Evidence

Reading pass · 15 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1992 PCBD1 (DCoH) is identical to 4a-carbinolamine dehydratase, demonstrating that a single polypeptide possesses both pterin dehydratase enzymatic activity (required for tetrahydrobiopterin regeneration in the phenylalanine hydroxylation system) and function as a dimerization cofactor that regulates HNF1alpha transcriptional activity. Protein purification, immunoblotting, dehydratase activity assay, stimulation of phenylalanine hydroxylase activity, cDNA cloning and sequencing Proceedings of the National Academy of Sciences of the United States of America High 1465414
1995 X-ray crystal structure of DCoH at 3 Å resolution reveals it forms a homotetramer with two saddle-shaped grooves as likely macromolecule binding sites, and two equivalent enzyme active sites flanking each saddle, suggesting spatial connection between catalytic and transcriptional coactivator binding activities. X-ray crystallography at 3 Å resolution Science (New York, N.Y.) High 7725101
1995 Crystal structure of PCD/DCoH at 2.7 Å resolution shows the homotetramer has a saddle-shaped eight-stranded antiparallel beta-sheet resembling the TATA-box binding protein, and establishes that the protein binds as a dimer to the helical dimerization domain of dimeric HNF1 forming a 2:2 heterotetramer, likely through a mixed four-helix bundle. X-ray crystallography solved by multiple isomorphous replacement, refined at 2.7 Å The EMBO journal High 7744010
1996 High-resolution (2.3 Å) crystal structure of DCoH and its complex with the product analogue 7,8-dihydrobiopterin shows the pterin binds at four equivalent active-site clefts within an arch of aromatic residues spanning one dimer interface, making contacts to three conserved histidines, constraining the dehydration mechanism. X-ray crystallography at 2.3 Å with ligand-bound complex Protein science : a publication of the Protein Society High 8897596
1997 DCoH stabilizes HNF1/DNA complexes and promotes HNF1 binding to sub-optimal DNA target sequences; DCoH completely abolishes HNF1-RNA interactions; DCoH retains its dehydratase enzymatic activity while complexed with HNF1 in the heterotetramer. In vitro binding assays with purified recombinant HNF1, HNF1/DCoH heterotetramers and DCoH homotetramers; gel-shift assays; enzymatic activity assay Journal of molecular biology High 8995521
1997 DCOH enzymatic (dehydratase) activity is not required for HNF1 binding; the HNF1 dimerization domain alone is sufficient for DCOH binding; both proteins co-localize in co-transfected cells. Yeast two-hybrid system with enzymatic mutants; co-transfection with co-localization analysis Nucleic acids research Medium 9092652
1998 Active-site mutagenesis establishes that His61 and His79 act as general acid catalysts for stereospecific elimination of the 4a(R)- and 4a(S)-hydroxyl groups, respectively, while His62 primarily binds substrate with an additional base catalysis component in the dehydratase reaction mechanism. Site-directed mutagenesis (H61A, H62A, H79A) combined with kinetic analysis using stereospecific substrate enantiomers, and diethylpyrocarbonate chemical modification Biochemistry High 9698371
1998 Mutations in the PCBD gene (T78I, E86X, Q97X) cause primapterinuria/hyperphenylalaninemia; recombinant expression shows mutant proteins are almost entirely insoluble, indicating proteolytic instability rather than direct catalytic disruption underlies the dehydratase deficiency. Genomic mutation analysis, recombinant expression in E. coli with solubility fractionation American journal of human genetics Medium 9585615
1998 DCoH/PCD is expressed as a maternal factor in rat eggs, enters cell nuclei at the 8-cell stage, and is present in tissues lacking HNF1 (eye pigmented epithelium, brain ependymal cells), demonstrating HNF1-independent nuclear functions during embryogenesis. Immunofluorescence localization, Western blotting, developmental expression analysis in rat embryos The International journal of developmental biology Medium 9496786
2000 Overexpression of DCoH/PCD in Xenopus induces ectopic pigment cells with increased tyrosinase activity and melanin; DCoH/PCD mutants with impaired carbinolamine dehydratase activity retain this pigmentation-inducing potential, indicating a regulatory role in pigment cell differentiation independent of enzymatic activity. Xenopus overexpression, animal cap explant assay, tyrosinase activity measurement, melanin quantification Mechanisms of development Medium 10704830
2002 DCoH null mice display hyperphenylalaninemia (consistent with tetrahydrobiopterin recycling defect) and mild glucose intolerance, but HNF1 function is only slightly impaired, establishing that a homolog DCoH2 partially compensates for loss of PCBD1 in HNF1-dependent transcription in vivo. Targeted gene deletion in mice; metabolic phenotyping; glucose tolerance testing The Journal of biological chemistry High 12011081
2003 DCoH/HNF-1alpha complex binds to the human tyrosinase promoter in human epidermal melanocytes, establishing tyrosinase as a transcriptional target of the DCoH/HNF-1alpha complex in skin pigmentation. Gel shift analysis (EMSA) with tyrosinase promoter, immunofluorescence co-localization in melanocytes in vitro and in situ Biochemical and biophysical research communications Medium 12565907
2004 DCoH2 (the PCBD1 homolog) forms a tetramer, displays pterin-4alpha-carbinolamine dehydratase activity, and binds HNF1alpha in vivo and in vitro; unlike the hyperstable DCoH tetramer, DCoH2 readily forms a 2:2 complex with HNF1, suggesting DCoH2 operates under thermodynamic control and DCoH under kinetic control in HNF1alpha regulation. 1.6 Å crystal structure of DCoH2, in vitro dehydratase assay, in vivo and in vitro HNF1alpha binding assays, phylogenetic analysis Biochemistry High 15182178
2013 PCBD1 acts as a coactivator of HNF1B-mediated transcription to stimulate the FXYD2 promoter in the distal convoluted tubule; five of seven disease-causing PCBD1 mutations cause proteolytic instability leading to reduced FXYD2 promoter activity; cytosolic localization of PCBD1 increases when co-expressed with HNF1B mutants, linking loss of nuclear HNF1B interaction to cytoplasmic retention of PCBD1. Overexpression in human kidney cell line, co-immunoprecipitation (PCBD1-HNF1B binding), FXYD2 promoter-reporter assay, subcellular localization by immunofluorescence, protein stability assay, gene expression analysis in mouse kidney DCT Journal of the American Society of Nephrology : JASN High 24204001
2014 PCBD1 is expressed in the developing pancreas co-localizing with insulin from early specification, and morpholino-mediated knockdown in Xenopus reveals that pcbd1 activity is required for proper establishment of early pancreatic fate within the endoderm. Morpholino knockdown in Xenopus embryos, immunofluorescence co-localization with insulin in mouse and Xenopus pancreas Diabetes Medium 24848070

Source papers

Stage 0 corpus · 32 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
1992 Identity of 4a-carbinolamine dehydratase, a component of the phenylalanine hydroxylation system, and DCoH, a transregulator of homeodomain proteins. Proceedings of the National Academy of Sciences of the United States of America 113 1465414
1994 Pseudomonas aeruginosa possesses homologues of mammalian phenylalanine hydroxylase and 4 alpha-carbinolamine dehydratase/DCoH as part of a three-component gene cluster. Proceedings of the National Academy of Sciences of the United States of America 86 8108417
2013 Mutations in PCBD1 cause hypomagnesemia and renal magnesium wasting. Journal of the American Society of Nephrology : JASN 59 24204001
1995 Crystal structure of DCoH, a bifunctional, protein-binding transcriptional coactivator. Science (New York, N.Y.) 53 7725101
1995 Three-dimensional structure of the bifunctional protein PCD/DCoH, a cytoplasmic enzyme interacting with transcription factor HNF1. The EMBO journal 45 7744010
1998 Hyperphenylalaninemia with high levels of 7-biopterin is associated with mutations in the PCBD gene encoding the bifunctional protein pterin-4a-carbinolamine dehydratase and transcriptional coactivator (DCoH). American journal of human genetics 44 9585615
2014 Recessive mutations in PCBD1 cause a new type of early-onset diabetes. Diabetes 42 24848070
1997 The bifunctional DCOH protein binds to HNF1 independently of its 4-alpha-carbinolamine dehydratase activity. Nucleic acids research 39 9092652
1993 Regulation of the HNF-1 homeodomain proteins by DCoH. Current opinion in genetics & development 35 8504250
1997 The bifunctional protein DCoH modulates interactions of the homeodomain transcription factor HNF1 with nucleic acids. Journal of molecular biology 34 8995521
1998 Mutations in the pterin-4alpha-carbinolamine dehydratase (PCBD) gene cause a benign form of hyperphenylalaninemia. Human genetics 32 9760199
1996 High-resolution structures of the bifunctional enzyme and transcriptional coactivator DCoH and its complex with a product analogue. Protein science : a publication of the Protein Society 28 8897596
1995 Characterization of the human PCBD gene encoding the bifunctional protein pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor for the transcription factor HNF-1 alpha. Biochemical and biophysical research communications 23 7763270
2003 In situ and in vitro evidence for DCoH/HNF-1 alpha transcription of tyrosinase in human skin melanocytes. Biochemical and biophysical research communications 22 12565907
1996 Structure and function of PCD/DCoH, an enzyme with regulatory properties. FEBS letters 22 8682201
2002 Hyperphenylalaninemia and impaired glucose tolerance in mice lacking the bifunctional DCoH gene. The Journal of biological chemistry 21 12011081
2004 Biochemical and structural basis for partially redundant enzymatic and transcriptional functions of DCoH and DCoH2. Biochemistry 20 15182178
1999 PhhB, a Pseudomonas aeruginosa homolog of mammalian pterin 4a-carbinolamine dehydratase/DCoH, does not regulate expression of phenylalanine hydroxylase at the transcriptional level. Journal of bacteriology 18 10217769
2005 In vivo and in vitro evidence for autocrine DCoH/HNF-1alpha transcription of albumin in the human epidermis. Experimental dermatology 15 15740590
2000 Ectopic pigmentation in Xenopus in response to DCoH/PCD, the cofactor of HNF1 transcription factor/pterin-4alpha-carbinolamine dehydratase. Mechanisms of development 15 10704830
1998 The bifunctional protein DCoH/PCD, a transcription factor with a cytoplasmic enzymatic activity, is a maternal factor in the rat egg and expressed tissue specifically during embryogenesis. The International journal of developmental biology 15 9496786
2006 Can the DCoHalpha isozyme compensate in patients with 4a-hydroxy-tetrahydrobiopterin dehydratase/DCoH deficiency? Molecular genetics and metabolism 12 16423549
1998 Stereospecificity and catalytic function of histidine residues in 4a-hydroxy-tetrahydropterin dehydratase/DCoH. Biochemistry 12 9698371
1995 Activity of the bifunctional protein 4a-hydroxy-tetrahydropterin dehydratase/DCoH during human fetal development: correlation with dihydropteridine reductase activity and tetrahydrobiopterin levels. Biochemical and biophysical research communications 11 8554621
2001 Differential expression of chicken dimerization cofactor of hepatocyte nuclear factor-1 (DcoH) and its novel counterpart, DcoHalpha. The Biochemical journal 9 11237869
1995 PCD/DCoH: more than a second molecular saddle. Structure (London, England : 1993) 9 8590013
2000 Hyperphenylalaninemia and 7-pterin excretion associated with mutations in 4a-hydroxy-tetrahydrobiopterin dehydratase/DCoH: analysis of enzyme activity in intestinal biopsies. Molecular genetics and metabolism 6 10924272
1993 Genes for the dimerization cofactor of hepatocyte nuclear factor-1 alpha (DCOH) are on human and murine chromosomes 10. Genomics 6 8486378
2001 Studies of the variability of the hepatocyte nuclear factor-1beta (HNF-1beta / TCF2) and the dimerization cofactor of HNF-1 (DcoH / PCBD) genes in relation to type 2 diabetes mellitus and beta-cell function. Human mutation 4 11668623
1998 Characterization of the chicken and rat DCoH gene domains using an improved ligation-mediated PCR method. Biological chemistry 4 9865610
2013 A novel PCBD gene mutation in an Iranian patient with hyperphenylalaninemia. Clinical laboratory 2 24133926
2016 DCoH: A novel biomarker for diagnosing acute kidney injury. Medical hypotheses 0 27692160

Missed literature

Know a paper Affinage missed for PCBD1? Flag it for the maintainers and the community.

No submissions yet.